Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 156 clinical trials
Diagnostic Validity of [18F]GP1 PET for Diagnosing Acute Deep Vein Thrombosis

The first-in-human study of [18F]GP1 positron emission tomography/computed tomography (PET/CT) showed that [18F]GP1 is safe and promising novel PET tracer for imaging acute venous

deep vein thrombosis
venous thrombosis
thromboembolism
d-dimer test
d-dimer
  • 2 views
  • 26 Jan, 2021
  • 1 location
The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR

Oral warfarin anticogulation for the prevention and treatment of patients with venous thromboembolism is one of the most used therapies in clinical practice. Patients require different

  • 9 views
  • 07 Nov, 2020
Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19

clinical trial is called bemiparin. Bemiparin is a drug authorized as a prevention and as a treatment for deep vein thrombosis (blood clots in one or more veins, generally in the legs) and venous

SARS
covid-19
d-dimer
coronavirus infection
  • 0 views
  • 24 Jan, 2021
  • 2 locations
Early Ambulation to Reduce Hospital Length of Stay

Early ambulation of inpatients has been shown to be a key driver of decreased LOS and also reduced adverse events such as venous thromboembolism (VTE). We will test if a patient wearable device

  • 0 views
  • 29 Jan, 2021
  • 1 location
Cancer-related Thromboembolic Disease

Patients with cancer are at particularly high risk of venous thromboembolism (VTE). The guidelines therefore strongly recommend thromboprophylaxis but recent surveys clearly show that

cancer
metastatic adenocarcinoma
adenocarcinoma
chemotherapy regimen
  • 8 views
  • 28 Jan, 2021
  • 2 locations
Evaluation of a Cardiovascular Active Prevention in Chronic Myeloid Leukemia on the Cardiovascular Morbi-mortality

toxicities are associated with the second- and third-generation TKIs. Nilotinib and ponatinib cardiovascular toxicity including arterial and venous thromboembolism has decrease the benefit/risk ratio, 10% of

nilotinib
cancer
leukemia
imatinib
ponatinib
  • 1 views
  • 13 Feb, 2021
  • 1 location
Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19

standard of care including low-molecular-weight heparin (LMWH) or unfractionated heparin (UFH) at prophylactic doses if applicable in the prevention of the composite of venous thromboembolism (deep vein

  • 0 views
  • 07 Mar, 2021
  • 33 locations
"How do Contrast Medias in Bone Cement Affect DXA Measurements After THR"

) is gaining popularity, especially in Norway. Beside luxation, infection and venous thromboembolism, the problem with aseptic loosening is a known complication. A marker for aseptic

  • 1 views
  • 07 Nov, 2020
  • 1 location
Single Shot Lumbar Erector Spinae Plane (ESP) Block in Total Hip Replacement (THR)

-operative complications, for instance, venous thromboembolism and chest infection have long been documented in literature. These complications can have a bearing on long term survival, and may be prevented

avascular necrosis
chronic pain
local anesthetics
arthritis
nausea and vomiting
  • 127 views
  • 27 Jan, 2021
  • 1 location
Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

This randomized phase III trial studies the best dose of apixaban and how well it works in preventing secondary cancer related venous thrombosis in cancer patients who have completed anticoagulation therapy. Apixaban may help in prevention by blocking some of the enzymes needed for venous thrombosis.

cancer
anticoagulation therapy
bilateral oophorectomy
anticoagulant therapy
metastasis
  • 121 views
  • 12 Mar, 2021
  • 38 locations